Comprehensive Rehabilitation Programme in People With Multiple Sclerosis: The RECONNECT-MS Study
- Sponsor
- Charles University, Czech Republic
- Study ID
- NCT07666958
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Individual Physiotherapy — BEHAVIORALFacilitation-based individual physiotherapy (Motor Programme Activating Therapy, Dynamic Neuromuscular Stabilisation, soft-tissue and mobilisation techniques). 50 minute sessions, twice weekly for 8 weeks, then 3 maintenance sessions at progressively extended intervals during weeks 9-12. Delivered by two alternating physiotherapists.
- Group Movement Awareness — BEHAVIORALThree small-group sessions (6-8 participants) of Feldenkrais Awareness Through Movement (ATM).
- Group Psychotherapy — BEHAVIORALThree 60-minute small-group sessions focused on stress management, emotion regulation, relaxation techniques, and psychoeducation.
- Nutritional Recommendations — OTHERWritten / online evidence-based nutritional recommendations for autoimmune disease.
Study Details
The goal of this clinical trial is to learn if a comprehensive rehabilitation programme can improve physical function, reduce fatigue, and raise quality of life in adults aged 18-65 with multiple sclerosis (MS). The study will also look at whether the programme leads to changes in brain function using magnetic resonance imaging (MRI). The main questions it aims to answer are: * Does the programme lower the overall impact of MS on daily life? * Does the programme improve walking, balance, and hand function? * Does the programme reduce the impact of fatigue? * Are there changes in brain connections after the programme? Each participant serves as their own comparison. They are tested 3 times: 2 months before the programme starts (T0), right before it starts (T1), and after 2 months of intensive treatment (T2). The period between T0 and T1, when no treatment is given, shows each person's natural changes over time. Participants will: * Attend individual physiotherapy twice a week for 2 months, then 3 follow-up sessions over the next month * Take part in 3 group movement-awareness sessions * Take part in 3 group psychotherapy sessions focused on stress management and relaxation * Receive written nutritional guidance for autoimmune conditions Tests include physical assessments, questionnaires about fatigue and quality of life, tremor measurement, and brain MRI scans. The results may help improve rehabilitation care for people with MS and support their ability to stay active in everyday and working life.
Key Dates
- First listed
- Jun 24, 2026
- Start date
- Jul 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Feb 28, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 45 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Comprehensive Rehabilitation ProgrammeParticipants receive a 3-month multidisciplinary rehabilitation programme combining individual physiotherapy (twice weekly for 2 months, followed by 3 maintenance sessions over the 3rd month), 3 group movement-awareness sessions (Feldenkrais ATM), 3 group psychotherapy sessions, and written nutritional recommendations.
Primary Outcome Measure
Change in MS-specific health impact (Multiple Sclerosis Impact Scale, MSIS-29 total score) [ Time Frame: Change from baseline (T1, immediately before intervention start) to T2 (2-month intensive intervention phase) ]
Central Contacts
- Marie Prochazkova, Ph.D.+420737449662
Find similar trials
Related Studies
- Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)Recruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Serum Auto-Antibodies in Neurological DiseasesEnrolling By Invitation · University of California, Davis · Sacramento, California
- Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- NARCOMS Registry: A Multiple Sclerosis RegistryRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas